APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pet Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Vaccine Market Outlook and Growth Opportunities 2026

Report ID 174024360420 December 2025202 pages

Choose your research edition.

Industry ResearchPet Vaccine Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pet Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Vaccine Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pet Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Vaccine market include CAHIC, Zoetis, Ringpu, Merck Animal Health, Keqian Biology, Jinyu Group, Virbac, Vetoquinol and Parnell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Vaccine Segment by Company

CAHIC

Zoetis

Ringpu

Merck Animal Health

Keqian Biology

Jinyu Group

Virbac

Vetoquinol

Parnell

Ouro Fino Saude

Meiji

Kyoritsu Seiyaku

Elanco Animal Health

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Animalcare Group

Pet Vaccine Segment by Type

Nasal Administration

Injection

Other

Pet Vaccine Segment by Application

Cat

Dog

Other

Pet Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pet Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Vaccine industry.

Chapter 3: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Vaccine Industry Trends Table 2. Pet Vaccine Industry Drivers Table 3. Pet Vaccine Industry Opportunities and Challenges Table 4. Pet Vaccine Industry Restraints Table 5. Global Pet Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Vaccine Revenue Share by Company (2021-2026) Table 7. Global Pet Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pet Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Pet Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pet Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Pet Vaccine Company, Product Type & Application Table 13. Global Pet Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Administration Table 18. Significant Companies of Injection Table 19. Significant Companies of Other Table 20. Global Pet Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pet Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Pet Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Pet Vaccine Sales Volume Share by Type (2021-2026) Table 24. Global Pet Vaccine Sales Volume Share by Type (2027-2032) Table 25. Global Pet Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pet Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Pet Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Pet Vaccine Sales Value Share by Type (2021-2026) Table 29. Global Pet Vaccine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cat Table 31. Significant Companies of Dog Table 32. Significant Companies of Other Table 33. Global Pet Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pet Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Pet Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Pet Vaccine Sales Volume Share by Application (2021-2026) Table 37. Global Pet Vaccine Sales Volume Share by Application (2027-2032) Table 38. Global Pet Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pet Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pet Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pet Vaccine Sales Value Share by Application (2021-2026) Table 42. Global Pet Vaccine Sales Value Share by Application (2027-2032) Table 43. Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pet Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Pet Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Pet Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Pet Vaccine Sales Market Share by Region (2027-2032) Table 48. Global Pet Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pet Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pet Vaccine Sales Value Share by Region (2021-2026) Table 51. Global Pet Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pet Vaccine Sales Value Share by Region (2027-2032) Table 53. Global Pet Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Pet Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Pet Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Global Pet Vaccine Sales Market Share by Country (2021-2026) Table 59. Global Pet Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Pet Vaccine Sales Market Share by Country (2027-2032) Table 61. Global Pet Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pet Vaccine Sales Value Market Share by Country (2021-2026) Table 63. Global Pet Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pet Vaccine Sales Value Market Share by Country (2027-2032) Table 65. CAHIC Company Information Table 66. CAHIC Business Overview Table 67. CAHIC Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. CAHIC Pet Vaccine Product Portfolio Table 69. CAHIC Recent Development Table 70. Zoetis Company Information Table 71. Zoetis Business Overview Table 72. Zoetis Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Zoetis Pet Vaccine Product Portfolio Table 74. Zoetis Recent Development Table 75. Ringpu Company Information Table 76. Ringpu Business Overview Table 77. Ringpu Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Ringpu Pet Vaccine Product Portfolio Table 79. Ringpu Recent Development Table 80. Merck Animal Health Company Information Table 81. Merck Animal Health Business Overview Table 82. Merck Animal Health Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck Animal Health Pet Vaccine Product Portfolio Table 84. Merck Animal Health Recent Development Table 85. Keqian Biology Company Information Table 86. Keqian Biology Business Overview Table 87. Keqian Biology Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Keqian Biology Pet Vaccine Product Portfolio Table 89. Keqian Biology Recent Development Table 90. Jinyu Group Company Information Table 91. Jinyu Group Business Overview Table 92. Jinyu Group Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Jinyu Group Pet Vaccine Product Portfolio Table 94. Jinyu Group Recent Development Table 95. Virbac Company Information Table 96. Virbac Business Overview Table 97. Virbac Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Virbac Pet Vaccine Product Portfolio Table 99. Virbac Recent Development Table 100. Vetoquinol Company Information Table 101. Vetoquinol Business Overview Table 102. Vetoquinol Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Vetoquinol Pet Vaccine Product Portfolio Table 104. Vetoquinol Recent Development Table 105. Parnell Company Information Table 106. Parnell Business Overview Table 107. Parnell Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Parnell Pet Vaccine Product Portfolio Table 109. Parnell Recent Development Table 110. Ouro Fino Saude Company Information Table 111. Ouro Fino Saude Business Overview Table 112. Ouro Fino Saude Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Ouro Fino Saude Pet Vaccine Product Portfolio Table 114. Ouro Fino Saude Recent Development Table 115. Meiji Company Information Table 116. Meiji Business Overview Table 117. Meiji Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Meiji Pet Vaccine Product Portfolio Table 119. Meiji Recent Development Table 120. Kyoritsu Seiyaku Company Information Table 121. Kyoritsu Seiyaku Business Overview Table 122. Kyoritsu Seiyaku Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Kyoritsu Seiyaku Pet Vaccine Product Portfolio Table 124. Kyoritsu Seiyaku Recent Development Table 125. Elanco Animal Health Company Information Table 126. Elanco Animal Health Business Overview Table 127. Elanco Animal Health Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Elanco Animal Health Pet Vaccine Product Portfolio Table 129. Elanco Animal Health Recent Development Table 130. Dechra Veterinary Products Company Information Table 131. Dechra Veterinary Products Business Overview Table 132. Dechra Veterinary Products Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Dechra Veterinary Products Pet Vaccine Product Portfolio Table 134. Dechra Veterinary Products Recent Development Table 135. Ceva Company Information Table 136. Ceva Business Overview Table 137. Ceva Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Ceva Pet Vaccine Product Portfolio Table 139. Ceva Recent Development Table 140. Boehringer Ingelheim Company Information Table 141. Boehringer Ingelheim Business Overview Table 142. Boehringer Ingelheim Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Boehringer Ingelheim Pet Vaccine Product Portfolio Table 144. Boehringer Ingelheim Recent Development Table 145. Animalcare Group Company Information Table 146. Animalcare Group Business Overview Table 147. Animalcare Group Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Animalcare Group Pet Vaccine Product Portfolio Table 149. Animalcare Group Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Pet Vaccine Distributors List Table 153. Pet Vaccine Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Pet Vaccine Product Image Figure 2. Global Pet Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Pet Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pet Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Administration Image Figure 10. Injection Image Figure 11. Other Image Figure 12. Global Pet Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Pet Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Pet Vaccine Sales Volume Share by Type (2021-2032) Figure 15. Global Pet Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pet Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Vaccine Sales Value Share by Type (2021-2032) Figure 18. Cat Image Figure 19. Dog Image Figure 20. Other Image Figure 21. Global Pet Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pet Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pet Vaccine Sales Volume Share by Application (2021-2032) Figure 24. Global Pet Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pet Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pet Vaccine Sales Value Share by Application (2021-2032) Figure 27. Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Pet Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pet Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pet Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pet Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pet Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pet Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pet Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pet Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pet Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pet Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pet Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pet Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pet Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pet Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pet Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pet Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pet Vaccine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pet Vaccine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Administration
  • Injection
  • Other
Applications
  • Cat
  • Dog
  • Other
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu
  • Merck Animal Health
  • Keqian Biology
  • Jinyu Group
  • Virbac
  • Vetoquinol
  • Parnell
  • Ouro Fino Saude
  • Meiji
  • Kyoritsu Seiyaku
  • Elanco Animal Health
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Pet Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Vaccine Market Dynamics
  1. 2.1 Pet Vaccine Industry Trends
  2. 2.2 Pet Vaccine Industry Drivers
  3. 2.3 Pet Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Vaccine Industry Restraints
3 Pet Vaccine Market by Company
  1. 3.1 Global Pet Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Pet Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Pet Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Pet Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Pet Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Vaccine Company Product Type and Application
  8. 3.8 Global Pet Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Vaccine Market by Type
  1. 4.1 Pet Vaccine Type Introduction
  2. 4.1.1 Nasal Administration
  3. 4.1.2 Injection
  4. 4.1.3 Other
  5. 4.2 Global Pet Vaccine Sales Volume by Type
  6. 4.2.1 Global Pet Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pet Vaccine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Pet Vaccine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Pet Vaccine Sales Value by Type
  10. 4.3.1 Global Pet Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pet Vaccine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Pet Vaccine Sales Value Share by Type (2021-2032)
5 Pet Vaccine Market by Application
  1. 5.1 Pet Vaccine Application Introduction
  2. 5.1.1 Cat
  3. 5.1.2 Dog
  4. 5.1.3 Other
  5. 5.2 Global Pet Vaccine Sales Volume by Application
  6. 5.2.1 Global Pet Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pet Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pet Vaccine Sales Value by Application
  10. 5.3.1 Global Pet Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pet Vaccine Sales Value Share by Application (2021-2032)
6 Pet Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Pet Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Pet Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Pet Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Pet Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Vaccine Sales Value Share by Country, 2025 VS 2032
7 Pet Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Pet Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Pet Vaccine Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Pet Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Ringpu
  14. 8.3.1 Ringpu Company Information
  15. 8.3.2 Ringpu Business Overview
  16. 8.3.3 Ringpu Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ringpu Pet Vaccine Product Portfolio
  18. 8.3.5 Ringpu Recent Developments
  19. 8.4 Merck Animal Health
  20. 8.4.1 Merck Animal Health Company Information
  21. 8.4.2 Merck Animal Health Business Overview
  22. 8.4.3 Merck Animal Health Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Animal Health Pet Vaccine Product Portfolio
  24. 8.4.5 Merck Animal Health Recent Developments
  25. 8.5 Keqian Biology
  26. 8.5.1 Keqian Biology Company Information
  27. 8.5.2 Keqian Biology Business Overview
  28. 8.5.3 Keqian Biology Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Keqian Biology Pet Vaccine Product Portfolio
  30. 8.5.5 Keqian Biology Recent Developments
  31. 8.6 Jinyu Group
  32. 8.6.1 Jinyu Group Company Information
  33. 8.6.2 Jinyu Group Business Overview
  34. 8.6.3 Jinyu Group Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Group Pet Vaccine Product Portfolio
  36. 8.6.5 Jinyu Group Recent Developments
  37. 8.7 Virbac
  38. 8.7.1 Virbac Company Information
  39. 8.7.2 Virbac Business Overview
  40. 8.7.3 Virbac Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Virbac Pet Vaccine Product Portfolio
  42. 8.7.5 Virbac Recent Developments
  43. 8.8 Vetoquinol
  44. 8.8.1 Vetoquinol Company Information
  45. 8.8.2 Vetoquinol Business Overview
  46. 8.8.3 Vetoquinol Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol Pet Vaccine Product Portfolio
  48. 8.8.5 Vetoquinol Recent Developments
  49. 8.9 Parnell
  50. 8.9.1 Parnell Company Information
  51. 8.9.2 Parnell Business Overview
  52. 8.9.3 Parnell Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Parnell Pet Vaccine Product Portfolio
  54. 8.9.5 Parnell Recent Developments
  55. 8.10 Ouro Fino Saude
  56. 8.10.1 Ouro Fino Saude Company Information
  57. 8.10.2 Ouro Fino Saude Business Overview
  58. 8.10.3 Ouro Fino Saude Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ouro Fino Saude Pet Vaccine Product Portfolio
  60. 8.10.5 Ouro Fino Saude Recent Developments
  61. 8.11 Meiji
  62. 8.11.1 Meiji Company Information
  63. 8.11.2 Meiji Business Overview
  64. 8.11.3 Meiji Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Meiji Pet Vaccine Product Portfolio
  66. 8.11.5 Meiji Recent Developments
  67. 8.12 Kyoritsu Seiyaku
  68. 8.12.1 Kyoritsu Seiyaku Company Information
  69. 8.12.2 Kyoritsu Seiyaku Business Overview
  70. 8.12.3 Kyoritsu Seiyaku Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kyoritsu Seiyaku Pet Vaccine Product Portfolio
  72. 8.12.5 Kyoritsu Seiyaku Recent Developments
  73. 8.13 Elanco Animal Health
  74. 8.13.1 Elanco Animal Health Company Information
  75. 8.13.2 Elanco Animal Health Business Overview
  76. 8.13.3 Elanco Animal Health Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Elanco Animal Health Pet Vaccine Product Portfolio
  78. 8.13.5 Elanco Animal Health Recent Developments
  79. 8.14 Dechra Veterinary Products
  80. 8.14.1 Dechra Veterinary Products Company Information
  81. 8.14.2 Dechra Veterinary Products Business Overview
  82. 8.14.3 Dechra Veterinary Products Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Dechra Veterinary Products Pet Vaccine Product Portfolio
  84. 8.14.5 Dechra Veterinary Products Recent Developments
  85. 8.15 Ceva
  86. 8.15.1 Ceva Company Information
  87. 8.15.2 Ceva Business Overview
  88. 8.15.3 Ceva Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ceva Pet Vaccine Product Portfolio
  90. 8.15.5 Ceva Recent Developments
  91. 8.16 Boehringer Ingelheim
  92. 8.16.1 Boehringer Ingelheim Company Information
  93. 8.16.2 Boehringer Ingelheim Business Overview
  94. 8.16.3 Boehringer Ingelheim Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
  96. 8.16.5 Boehringer Ingelheim Recent Developments
  97. 8.17 Animalcare Group
  98. 8.17.1 Animalcare Group Company Information
  99. 8.17.2 Animalcare Group Business Overview
  100. 8.17.3 Animalcare Group Pet Vaccine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Animalcare Group Pet Vaccine Product Portfolio
  102. 8.17.5 Animalcare Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Vaccine Value Chain Analysis
  2. 9.1.1 Pet Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Vaccine Sales Mode & Process
  6. 9.2 Pet Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Vaccine Distributors
  9. 9.2.3 Pet Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst